Although a number of studies have revealed that T cells expand clonally in the joints of patients suffering from rheumatoid arthritis (RA), the kinetics of T cell clonality in multiple joints of an individual throughout progression of the disease is not known. By employing a TCR b chain genespeci®c RT-PCR and subsequent single-strand conformation polymorphism, which enables us to monitor T cell clonality, we analyzed transgenic mice (Tg) carrying the human T cell leukemia virus type I env-pX region. These mice spontaneously develop destructive progressive arthritis similar to RA as they age. In the early stage, the majority of accumulating T cell clones differed in each of four affected feet analyzed. However, in the advanced stage, many of the clones were common to all four feet. The total number of distinct clones gradually decreased as the disease progressed. When splenocytes from arthritic elder Tg were adoptively transferred into either nude mice or young Tg, the clones common to all four feet of the donor were detected again in four feet of the recipients. These ®ndings suggest that, as arthritis progresses, the T cell clones accumulating in the arthritic joints are gradually restricted to certain common clonotypes, some of which are arthrotropic.
Introduction
Rheumatoid arthritis (RA) is a chronic in¯ammatory disease characterized by persistent in¯ammation of synovium, destruction of cartilage and bone, and systemic illness. Based on the association with particular HLA alleles (1±3), massive in®ltration of T cells into the synovial tissues (4) and T cell oligoclonal expansion in the joints (5), T cells have been proposed to play an important role in RA pathogenesis: T cells would initiate or be involved in the in¯ammatory process by recognizing some antigens and producing cytokines (5, 6) , although this viewpoint has been controversial (7) .
We and others have demonstrated that T cells expand clonally in the synovium as well as the synovial¯uid of RA patients (5,8±14). Furthermore, some clones were found to be common in multiple joints of the same patient (14) . These ®ndings suggest that the oligoclonally accumulated common T cell clones are neither transiently nor randomly recruited into the in¯ammatory sites, but that they recognize some antigens which are associated with the pathogenesis of RA in¯ammation. Supporting this viewpoint, Mima et al. reported that T cell clones with an identical V b CDR3 sequence frequently detected in the joints of some RA patients induced synovial hyperplasia in SCID mice when these clones were transferred (15) .
In autoimmune disease murine models, it has been demonstrated that determinant spreading may be necessary for development of the full autoimmune syndrome (16±20). This epitope spreading occurs in experimental autoimmune encephalomyelitis, which is initiated by immunization of autoantigen peptides, as well as in NOD mice, a spontaneous autoimmune diabetes model. Both models are known to be mediated by T cells. This ampli®cation of the autoimmune response by recruitment of T cells with additional speci®cities would lead to clonality diversi®cation. Recently, it was reported that a shift towards a high-avidity pathogenic T cell population may be the key event in the progression of benign insulitis to overt diabetes in NOD mice (21) . Alternatively, the clonality of the lesion might be restricted toward T cells which are able to accumulate preferentially and to surpass other clones, because of their advantage to expand clonally responding to the antigen released from the destroyed in¯amed joint. Whether the clonality in the lesion continues to increase the diversity due to determinant spreading or decrease the variety is especially important in relation to T cell clonotype-targeted therapy. If the clonality becomes restricted, then regulation of a smaller number of clones should be suf®cient to achieve antigen-speci®c immunotherapy. Thus, studies of the dynamics of clonality are of great signi®cance.
So far, studies of T cell clonality have been performed using samples from patients with rather advanced disease. Although information on the dynamics of the clonality during the disease course from the early to the late stage could provide more profound insights into the pathogenic clones, kinetics studies of expanded clones in multiple joints at several time points throughout the disease course are not realistic, because of the dif®culty of sampling during the long and heterogeneous clinical time course of RA. It is also dif®cult to appreciate and to compare the signi®cance of expanded clones among patients, since RA patients are diverse and heterogeneous in terms of the disease severity, duration and modi®cation by treatment.
Transgenic mice (Tg) carrying the env-pX region of the human T cell leukemia virus type I (HTLV-I) genome spontaneously develop chronic in¯ammatory arthritis as they age (22) . The histopathologic characteristics of the joints of arthritic Tg closely resemble those found in patients with RA, showing proliferation of synovial lining cells, in®ltration of in¯ammatory cells with lymph follicle-like structures, and formation of pannus-like granulation tissue with destruction of cartilage and subchondral bone (23) . Genes for in¯amma-tory cytokines, including IL-1a, IL-1b, IL-6, tumor necrosis factor-a, transforming growth factor-b1, IFN-g and IL-2, as well as MHC genes are activated in joints. Moreover, these mice develop autoantibodies against IgG, type II collagen and heat-shock proteins (24) . A T cell response to type II collagen (25) and loss of T cell tolerance in the periphery are also demonstrated (26) . These pathological features are similar to those of RA. Therefore, the Tg are suitable for investigating T cell clonality during the disease course and its contribution to arthritis.
In the present study, using this spontaneous RA model HTLV-I env-pX Tg, we investigated the dynamics of the T cell clonotype in the affected four feet during the disease progression. We found clonally expanded T cells, some of which were common to all four in¯amed feet. Surprisingly, as the disease progressed, the number of common clonotypes among the different feet increased, whereas the total number of clonotypes decreased. Adoptive transfer studies revealed that these common clonotypes of the donor feet migrated into the feet of the recipients, whose arthritis was exacerbated by the transfer. These results provide evidence that T cells in the in¯amed joints are rather restricted to certain common clonotypes.
Methods

Mice
HTLV-I env-pX Tg were backcrossed to BALB/c mice for more than eight generations. The mice were maintained under speci®c pathogen-free conditions in the animal facility of the University of Tokyo, Graduate School of Medicine. All experiments using animals were performed according to the guidelines for animal experiments in our institution.
Clinical evaluation
The severity of arthritis was assessed using a clinical scoring system of 0±3: 0 = normal, 1 = redness and swelling, 2 = deformity, and 3 = ankylosis (27) . Each foot was scored and the total score was determined; the maximum possible score per mouse was 12. Tg were divided into three groups by the arthritis stage: early stage (age: 5±10 weeks; score: 0±3), mid stage (age: 4±5 months; score: 6±8) and late stage (age: 7±8 months; score: 10±12).
Analysis of T cell clonality by RT-PCR/single-strand conformation polymorphism (SSCP)
Joint tissues were obtained from the front and back feet of Tg after removal of skin and muscle. Total RNA was prepared with Isogen (Nippon Gene, Tokyo, Japan) and then converted to cDNA with reverse transcriptase (Superscript II; Gibco/BRL, Gaithersburg, MD) and random hexamer oligonucleotide (Gibco/BRL) at 42°C for 2±3 h. PCR was performed with 100±200 ng of cDNA, 50 pmol of each of the 22 V b primers and 50 pmol of a common C b primer, dNTPs, and 1 U of Taq polymerase (Takara, Otsu, Japan) for 35 cycles (94°C for 1 min, 54°C for 2 min and 72°C for 3 min) in a Thermal Cycler 9600 (Perkin-Elmer, Norwalk, CT). The sequences of the V b primers were obtained from published data (28) . The sequence of C b primer was 5¢-GGCTCAAACAAGGAG-ACCTTG-3¢. SSCP analysis was performed as follows. Ampli®ed DNA was diluted (1:2±1:20) with a denaturing solution (95% formamide, 10 mM EDTA, 0.1% bromophenol blue and 0.1% xylene cyanol), heat denatured at 90°C for 2 min and electrophoresed on non-denaturing 4% polyacrylamide gels containing 10% glycerol. After electrophoresis, the DNA was transferred onto GeneScreen (NEB, Beverly, MA) and then hybridized with a biotinylated internal common C b oligonucleotide probe (5¢-AGGATCTGAGAAATGTGA-3¢). The bound C b probe was detected using a Phototope-Star detection kit (NEB).
The number of T cell clonotypes was calculated by three researchers independently who did not know the sample sources.
Standardization of TCR mRNA
To adjust the amount of TCR mRNA in spleen to that of joint for SSCP analysis, we conducted real-time quantitative PCR on the iCycler iQ real-time detection system (Bio-Rad, Hercules, CA). PCR was performed using QuantiTect SYBR Green PCR kit (Qiagen, Hilden, Germany) according to the manufacturer's instructions. For the ampli®cation of the C b region, 5¢-GGTCTCCTTGTTTGAGCCAT-3¢ was used as the 5¢ primer and 5¢-ACTGATGTTCTGTGTGACAG-3¢ as the 3¢ primer. The housekeeping gene b-actin (5¢-TCACCCACACTGTGCCC-ATCTAC-3¢, 5¢-ACGATTTCCCTCTCAGCTGTGG-3¢) was chosen for internal normalization.
Sequence analysis
TCR V b genes extracted from SSCP polyacrylamide gels were re-ampli®ed using the same TCR V b and C b primer as primary PCR. The re-ampli®ed TCR V b gene was subcloned to a plasmid vector (pGEM-T Easy Vector; Promega, Madison, MI). Nucleotide sequences of the TCR V b genes were determined by the dideoxy method using a 310 Genetic Analyzer (PerkinElmer/Applied Biosystems, Foster, CA).
Adoptive transfer experiment
Spleens were removed aseptically from arthritic Tg in the late stage and control mice. As a control, we used non-arthritic Tg aged 4±6 weeks which had not developed the arthritis. Singlecell suspensions were prepared by teasing apart the spleens in HBSS and pushing them through a metal sieve with a syringe barrel. After washing with HBSS, 2±5Q10 7 splenic cells were injected into either young Tg (6±7 weeks) with the onset of overt arthritis (the total score was <1±2) or BALB/c nu/nu mice. After 3 weeks, these recipients were sacri®ced and then subjected to RT-PCR/SSCP analysis to examine the T cell clonotypes accumulated in the joints.
Statistical analysis
Data was analyzed using statistical software (Statcel, Saitama, Japan) and expressed as the mean T SEM. The rate of common T cell clonotypes in all four feet and the arthritis score were compared by Student's t-test, and the total number of T cell clonotypes by Mann±Whitney's U-test.
Results
Accumulation of T cell clonotypes in arthritic joints of HTLV-I env-pX Tg
Arthritis in the Tg was discerned as swelling and redness of the footpad, including the ankle. The abnormality began to occur at age 4±8 weeks and thereafter the grade of arthritis increased as the animal aged. The clinical score ®nally reached the maximum at~6 months (Fig. 1) . Thus, since the disease severity was closely related to the age, we divided Tg into three groups according to their age, i.e. early stage (age: 5±10 weeks; score: 1±3), mid stage (age: 4±5 months; score: 6±8) and late stage (age: 7±8 months; score: 10±12).
We analyzed the T cell clonotypes in®ltrating the joints of all four feet from HTLV-I env-pX Tg at 5 months (the mid stage) using the TCR/RT-PCR/SSCP method (Fig. 2) . While the spleen exhibited smear patterns indicating a diverse T cell population consisting of heterogeneous CDR3 regions of TCR, accumulation of several distinct bands was observed in the feet. These results indicate that T cells expand oligoclonally in the joints of all four feet, as has been shown for the joints of RA patients. The number of common T cell clonotypes increased, whereas the total number of T cell clonotypes decreased as the disease advanced
To investigate the change in T cell clonality during the progression of arthritis, we compared T cell clonotypes in the early, mid and late stages. The T cell clonotypes which accumulated in each joint of the four feet showed different mobility in the early stage, but they migrated to an identical position in the late stage (Fig. 3) . Bands with the same mobility on SSCP gels had been demonstrated to possess the same nucleotide sequences (13, 29, 30) and we ourselves always con®rm this rule by DNA sequencing. Therefore, bands with identical migration in SSCP represent identical clones.
We counted the total number of T cell clonotypes detected in each foot and the number of common clonotypes among the four feet. The results are summarized in Table 1 . The proportion of T cell clonotypes common to all four feet was low in each V b repertoire in the early stage (average 14.1%). However, it increased during progression of the stage. This increase during the transition from the early to late stage was observed in many V b repertoires (V b 2 and 6, P < 0.0001; V b 7, P < 0.001; V b 8.1 and 8.2, P = 0.001; V b 8.3, 10, 11 and 15, P < 0.05). Finally in the late stage, a high rate of >70% was found for V b 2, 6, 7, 8.1, 8.2, 8.3 and 10 (Fig. 4) . Of interest, in contrast to the common clones, the total number of T cell clonotypes accumulated in joints decreased as the disease advanced (P < 0.05) ( Table 1 ). In particular, V b 2, 6, 7 and 8.1 are striking, showing that the total number of T cell clonotypes in the late stage decreased by 40±50% compared with in the early stage. Taken together, the T cell clonotypes became identical while reducing their variety during progression of arthritis.
To examine amino acid sequences of the CDR3 region in common T cell clonotypes among four feet, DNA encoding the V b genes were collected from SSCP gels and sequenced. As shown in Table 2 , conserved amino acid motifs were found, e.g. QGW in the CDR3 region of V b 2 clones, RGTG in V b 9, and SXTGG, LTGG, QGA and YRG in V b 10. In addition, certain conserved amino acid motifs, such as RSG in V b 2 and V b 9, DWG in V b 2 and V b 10, and IQG and QGA in V b 10 and V b 11, were observed in the CDR3 region of different V b clones. This sequence information implies the possibility that T cell clonotypes in multiple joints might recognize some common epitopes on antigens.
The common clones were able to migrate into the joints of the recipients
In order to investigate the pathological signi®cance of the common clonotypes in four feet, we conducted an adoptive transfer experiment. First, splenocytes derived from an arthritic Tg were transferred into nude mice. The joints of the feet of the recipients showed just mild swelling transiently. Nevertheless, clonotype analysis revealed that some common clones of the donors migrated into the feet of the recipients (Fig. 5 ).
Since non-T cell components are considered to be indispensable for inducing the persistent arthritis (31), we selected young Tg as recipients. In each experiment, splenic cells either from an arthritic Tg (experimental group) or a nonarthritic Tg (control group) were transferred into two young Tg with the onset of arthritis. Three weeks after the transfer, the arthritis score of the recipients from an arthritic Tg was signi®cantly higher than that of recipients from non-arthritic Tg and that of non-treated Tg (Fig. 6 ). This result suggests that the progression of arthritis was accelerated by the transfer of splenocytes from arthritic mice and that the T cells from the donors were involved in the exacerbation of the arthritis. Three weeks after the transfer, these recipients were sacri®ced and subjected to T cell clonality analysis. Some identical T cell clonotypes were detected in the donor and the two recipients, indicating that these identical T cell clonotypes accumulated in the joints of the recipients originated from the donors (Fig. 7) . Since the smear pattern of the clonotype in the spleen of the recipients suggests that the degree of clonotype expansion is different between the joints and spleen, and since the common T cell clonotype between all four feet of the donor and recipient was not dominant in the spleen, we were able to rule out the possibility that the clonotype in joints simply re¯ects that of the spleen.
To verify that the clonotypes common to the donors and the recipients possess the identical TCR V b chain sequences in transfer experiments, DNA was recovered from the bands with same mobility on SSCP gels and sequences were determined. Table 3 shows the DNA sequences of SSCP bands from a donor and recipient, shown by arrows in Figs 5 and 7. As expected, the sequences were identical between the donor and recipient. These ®ndings indicate that some of the common clonotypes in four feet of the donor in®ltrated again Table 2 . The TCR VDJ region of common T cell clonotypes in four feet
Underlined letters indicate conserved amino acid motifs. into the joints of the recipient. There were no clear conserved amino acids among migrated clonotypes in the amino acid sequences of the CDR3 region.
Discussion
We studied the T cell clonotypic change in arthritic joints of HTLV-I env-pX Tg during the development of the disease. In the early stage of the disease, T cell clonotypes diversi®ed among the feet. On the contrary, in the late stage, most of the clonotypes were common to all four feet. The total number of accumulating clones decreased compared with in the early stage. Thus, the T cell clonotypes became identical and decreased in variety as the disease progressed. Some of these common clones remaining in the late stage joints might be arthrotropic, since the transfer studies revealed their ability to migrate into the joints. Due to the restricted availability of clinical samples, it might have been dif®cult to know the dynamic changes of clonality, which are diverse at the initial stage and ®nally are restricted to common clonotypes. Analysis of T cell clonality in the joints of RA patients as well as in the affected organs of autoimmune disease animal models demonstrated the presence of common clonotypes among multiple joints or among different parts of an organ (13, 28) . Moreover, the amino acid sequences of TCR V b junctional regions of clones which are identical in multiple joints of a patient were found to be the same as the sequences of the common clones of different patients (14) . Considering that CDR3 interacts with the peptides presented by MHC molecules (32±34), these identical clones might recognize certain common antigens which are involved in the pathogenesis of RA. Our identi®cation of common clonotypes in the four arthritic feet and some conserved CDR3 motifs among them is consistent with these previous ®ndings.
In our present study of HTLV-I env-pX Tg, the accumulation of common clonotypes was distinct after the mid stage, whereas in the early stage it was not so pronounced. How can this change in clonality during disease progression be explained?
Several studies have implicated epitope spreading in the pathogenesis of autoimmune diseases (16±20). Disease progression is associated with a shifting of T cell autoreactivity from primary initiating self-antigenic determinants to de®ned cascades of secondary determinants that sustain the selfrecognition involved in disease perpetuation. Intramolecular as well as intermolecular epitope spreading could presumably occur by antigen presentation of autoantigens derived from destroyed tissues (35±37). As recruitment of T cells speci®c for additional determinants continues, T cell clonality should become diversi®ed. In our experiment, the early stage might ®t the epitope-spreading model. The recruitment of T cells with other speci®city proceeded independently in each joint. Since the time of onset of the arthritis is different among the four feet, it is also possible that the degree of autoimmune response propagation differs in each foot, resulting in the accumulation of different clones in each joint. The autoantigens driving the autoimmune response in each joint may differ in this stage. However, epitope spreading may not explain the T cell behavior in our arthritis model throughout the entire course of the disease, since the total number of T cell clones . Young Tg developed more severe arthritis after receiving splenocytes from an arthritic Tg. Splenocytes from an arthritic Tg or a non-arthritic Tg were transferred to young Tg on clinical onset, as described in Methods. The arthritis score at 3 weeks after cell transfer was judged. Note that the score of the recipients from an arthritic Tg (open circles) was signi®cantly higher than that of recipients from a non-arthritic Tg (sold circles) and that of the non-treated Tg (open squares) (*P < 0.001, **P < 0.0005). decreased and the identity of clonality increased with disease progression.
It is shown that the TCR repertoire of memory cells which expand selectively during the recall response are rather restricted (38) . Thus, such clones might be increasing while an autoantigen repetitively stimulates and drives the (pathogenic) immune response. Adding to this, some autoreactive T cell clones might be inactivated or deleted by regulatory mechanisms. Therefore, we may reason that the number of accumulating clones in the lesion of an autoimmune disease might gradually decrease, leaving clones which are able to expand more ef®ciently or are less susceptible to cell death.
Alternatively, the clonal restriction in the joints might re¯ect avidity maturation of a T cell population. Amrani et al. demonstrated that a shift towards a high-avidity pathogenic T cell population may be the key event in the progression of benign insulitis to overt diabetes using NOD mice (21) . Applying this hypothesis, we tend to prefer that some of the remaining common clonotypes have an advantage in clonal expansion due to their higher avidity for certain autoantigens and are related to the in¯ammation of the joints. However, it is too early to conclude that the remaining common clonotypes are pathogenic, since other clones might also be involved in the exacerbation of young Tg arthritis after the transfer.
Nevertheless, some of them are at least arthrotropic since they migrated to the joints of the recipients, implying that they recognize a certain autoantigen in the joint. Since it has indeed been demonstrated that dominant T cell clones in Tg recognize collagen type II (25) , Tax and Env of the pX products (39) , it would be of great interest to investigate whether these common clones respond to those antigens.
Taken together, during the perpetuation of arthritis, T cell clonality decreased in variety and was restricted to the clones, some of which are arthrotropic and might be related to the pathogenesis of arthritis. This`clonal restriction' phenomena should be veri®ed in other autoimmune diseases and its models to develop antigen-speci®c immunotherapy targeting certain common T cell clonotypes. 
